286 related articles for article (PubMed ID: 36066263)
21. Acinetobactin-Mediated Inhibition of Commensal Bacteria by Acinetobacter baumannii.
Knauf GA; Powers MJ; Herrera CM; Trent MS; Davies BW
mSphere; 2022 Feb; 7(1):e0001622. PubMed ID: 35138126
[TBL] [Abstract][Full Text] [Related]
22. Iron limitation enhances acyl homoserine lactone (AHL) production and biofilm formation in clinical isolates of Acinetobacter baumannii.
Modarresi F; Azizi O; Shakibaie MR; Motamedifar M; Mosadegh E; Mansouri S
Virulence; 2015; 6(2):152-61. PubMed ID: 25622119
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis of iron-regulated membrane proteins identify FhuE receptor as a target to inhibit siderophore-mediated iron acquisition in Acinetobacter baumannii.
Tiwari V; Rajeswari MR; Tiwari M
Int J Biol Macromol; 2019 Mar; 125():1156-1167. PubMed ID: 30579900
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of an outer membrane receptor gene in Acinetobacter baumannii required for utilization of desferricoprogen, rhodotorulic acid, and desferrioxamine B as xenosiderophores.
Funahashi T; Tanabe T; Mihara K; Miyamoto K; Tsujibo H; Yamamoto S
Biol Pharm Bull; 2012; 35(5):753-60. PubMed ID: 22687412
[TBL] [Abstract][Full Text] [Related]
25. Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular
Choi SR; Britigan BE; Narayanasamy P
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30782994
[TBL] [Abstract][Full Text] [Related]
26. Outer Membrane Vesicles of
Dhurve G; Madikonda AK; Jagannadham MV; Siddavattam D
Microbiol Spectr; 2022 Apr; 10(2):e0029322. PubMed ID: 35266817
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the Virulence Factors and Molecular Characterization of the Clonal Relations of Multidrug-Resistant
Ali HM; Salem MZM; El-Shikh MS; Megeed AA; Alogaibi YA; Talea IA
J AOAC Int; 2017 Jan; 100(1):152-158. PubMed ID: 27765082
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic-Resistant
Parquet MDC; Savage KA; Allan DS; Ang MTC; Chen W; Logan SM; Holbein BE
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209004
[No Abstract] [Full Text] [Related]
30. Iron uptake mechanisms as key virulence factors in bacterial fish pathogens.
Lemos ML; Balado M
J Appl Microbiol; 2020 Jul; 129(1):104-115. PubMed ID: 31994331
[TBL] [Abstract][Full Text] [Related]
31. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.
McConnell MJ; Actis L; Pachón J
FEMS Microbiol Rev; 2013 Mar; 37(2):130-55. PubMed ID: 22568581
[TBL] [Abstract][Full Text] [Related]
32. Synthetic Mimics of Native Siderophores Disrupt Iron Trafficking in
Bohac TJ; Fang L; Banas VS; Giblin DE; Wencewicz TA
ACS Infect Dis; 2021 Aug; 7(8):2138-2151. PubMed ID: 34110766
[TBL] [Abstract][Full Text] [Related]
33. [Current approaches to explain the virulence of Acinetobacter baumannii].
Aşık G
Mikrobiyol Bul; 2011 Apr; 45(2):371-80. PubMed ID: 21644082
[TBL] [Abstract][Full Text] [Related]
34. Functional features of TonB energy transduction systems of Acinetobacter baumannii.
Zimbler DL; Arivett BA; Beckett AC; Menke SM; Actis LA
Infect Immun; 2013 Sep; 81(9):3382-94. PubMed ID: 23817614
[TBL] [Abstract][Full Text] [Related]
35. Iron and Virulence in
Kalidasan V; Joseph N; Kumar S; Awang Hamat R; Neela VK
Front Cell Infect Microbiol; 2018; 8():401. PubMed ID: 30483485
[No Abstract] [Full Text] [Related]
36. Synthesis and Characterization of Preacinetobactin and 5-Phenyl Preacinetobactin.
Bray JM; Pierce S; Angeles-Boza AM; Peczuh MW
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744823
[TBL] [Abstract][Full Text] [Related]
37. Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.
Dehbanipour R; Ghalavand Z
J Clin Pharm Ther; 2022 Nov; 47(11):1875-1884. PubMed ID: 36200470
[TBL] [Abstract][Full Text] [Related]
38. In vivo validation of the immunogenicity of recombinant Baumannii Acinetobactin Utilization A protein (rBauA).
Esmaeilkhani H; Rasooli I; Nazarian S; Sefid F
Microb Pathog; 2016 Sep; 98():77-81. PubMed ID: 27374893
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of iron utilization by Mycobacterium tuberculosis.
Zhang L; Hendrickson RC; Meikle V; Lefkowitz EJ; Ioerger TR; Niederweis M
PLoS Pathog; 2020 Feb; 16(2):e1008337. PubMed ID: 32069330
[TBL] [Abstract][Full Text] [Related]
40. Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T.
Mihara K; Tanabe T; Yamakawa Y; Funahashi T; Nakao H; Narimatsu S; Yamamoto S
Microbiology (Reading); 2004 Aug; 150(Pt 8):2587-2597. PubMed ID: 15289555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
